FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $11,363,000 | +2592.7% | 668,000 | +3370.7% | 0.04% | +975.0% |
| Q4 2017 | $422,000 | -46.4% | 19,247 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $787,000 | +35.7% | 19,247 | 0.0% | 0.01% | +20.0% |
| Q2 2017 | $580,000 | -16.7% | 19,247 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $696,000 | -27.8% | 19,247 | 0.0% | 0.01% | -33.3% |
| Q4 2016 | $964,000 | -4.6% | 19,247 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $1,010,000 | +26.9% | 19,247 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $796,000 | +1.8% | 19,247 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $782,000 | -2.1% | 19,247 | 0.0% | 0.01% | +14.3% |
| Q4 2015 | $799,000 | +169.9% | 19,247 | 0.0% | 0.01% | +133.3% |
| Q3 2015 | $296,000 | -38.1% | 19,247 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $478,000 | +8.6% | 19,247 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $440,000 | -17.8% | 19,247 | -2.9% | 0.00% | -20.0% |
| Q4 2014 | $535,000 | +129.6% | 19,823 | 0.0% | 0.01% | +66.7% |
| Q3 2014 | $233,000 | -24.4% | 19,823 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $308,000 | -21.0% | 19,823 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $390,000 | +17.1% | 19,823 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $333,000 | – | 19,823 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|